Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Locomotion (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Locomotion < Locomotion (drug effects) < Locomotion (genetics)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000281 (2000) H A Jinnah [États-Unis] ; J P Sepkuty ; T. Ho ; S. Yitta ; T. Drew ; J D Rothstein ; E J HessCalcium channel agonists and dystonia in the mouse.
000329 (2000) S A Treseder [Royaume-Uni] ; L A Smith ; P. JennerEndogenous dopaminergic tone and dopamine agonist action.
000647 (2002) Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta ImperatoNeuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000887 (2002) Lance A. Smith [Royaume-Uni] ; Banu C. Tel ; Michael J. Jackson ; Matthew J. Hansard ; Rogelio Braceras ; Céline Bonhomme ; Claire Chezaubernard ; Susanna Del Signore ; Sarah Rose ; Peter JennerRepeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.
000A52 (2003) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Matthew J. Hansard ; Eleni Maratos ; Peter JennerEffect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure.
000C55 (2003) Nancy Bélanger [Canada] ; Laurent Grégoire ; Abdallah Hadj Tahar ; Paul J. BédardChronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys.
000C82 (2004) Matthew J. Hansard [Royaume-Uni] ; Lance A. Smith ; Michael J. Jackson ; Sharon C. Cheetham ; Peter JennerThe monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.
001074 (2005) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Ghassan Al-Barghouthy ; Sarah Rose ; Mikko Kuoppamaki ; Warren Olanow ; Peter JennerMultiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.
001103 (2005) Fredricka C. Martin [États-Unis] ; Anh Thu Le ; Adrian HandforthHarmaline-induced tremor as a potential preclinical screening method for essential tremor medications.
001B33 (2007) Regina Katzenschlager [Royaume-Uni] ; Michael J. Jackson ; Sarah Rose ; Kim Stockwell ; Kayhan A. Tayarani-Binazir ; Mohammed Zubair ; Lance A. Smith ; Peter Jenner ; Andrew J. LeesAntiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets.
002D81 (2010) Louisa Clare Johnston [Royaume-Uni] ; Michael John Jackson ; Sarah Rose ; Andrew Christopher Mccreary ; Peter JennerPardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets.
004804 (1993) A J Stoessl [Canada] ; E. Polanski ; H. FrydryszakThe opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia.
004806 (1993) C A Hubbard ; J M TrugmanReversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonists.
004A00 (1993) B. Johnels [Suède] ; P E Ingvarsson ; B. Holmberg ; M. Matousek ; G. StegSingle-dose L-dopa response in early Parkinson's disease: measurements with optoelectronic recording technique.
004A08 (1993) B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P J BédardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.
004A71 (1996) L. Smith [Royaume-Uni] ; M. De Salvia ; P. Jenner ; C D MarsdenAn appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
004C77 (1997) A. Burleigh-Jacobs [États-Unis] ; F B Horak ; J G Nutt ; J A ObesoStep initiation in Parkinson's disease: influence of levodopa and external sensory triggers.
005036 (1998) A P Payne [Royaume-Uni] ; R G Sutcliffe ; J M Campbell ; G. Favor ; D. Russell ; N K Bennett ; D J Clarke ; R. Branton ; R W Davies ; E. Simpson ; C. Tsang ; R H BaxendaleDisordered locomotion in the AS/AGU mutant rat and the effects of L-dopa or fetal midbrain grafts.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Locomotion (drug effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Locomotion (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Locomotion (drug effects)
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024